DETERMINATION OF THALIDOMIDE AND ITS MAJOR METABOLITES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

[1] BECKMANN R, 1961, ARZNEIMITTEL-FORSCH, V11, P45

[2] BECKMANN R, 1963, Arzneimittelforschung, V13, P185

[3] ERIKSSON SO, 1973, ACTA PHARM SUEC, V10, P63

[4] GREEN JN, 1964, J PHARM PHARM S, V16, pT117

[5] Koch H., 1981, SCI PHARM, V49, P67

[6] Koch H, 1971, SCIENTIA PHARMAC WIE, V39, P209

[7] Koch H P, 1985, Prog Med Chem, V22, P165, DOI 10.1016/S0079-6468(08)70231-5

[8] PAULUS W., 1963, ARCH TOXIKOLOGIE, V20, P38

[9] PISCHEK G, 1970, MIKROCHIM ACTA, P530

[10] SAID AS, 1981, THEORY MATH CHROMATO, P162

[1] BECKMANN R, 1961, ARZNEIMITTEL-FORSCH, V11, P45

[2] BECKMANN R, 1963, Arzneimittelforschung, V13, P185

[3] ERIKSSON SO, 1973, ACTA PHARM SUEC, V10, P63

[4] GREEN JN, 1964, J PHARM PHARM S, V16, pT117

[5] Koch H., 1981, SCI PHARM, V49, P67

[6] Koch H, 1971, SCIENTIA PHARMAC WIE, V39, P209

[7] Koch H P, 1985, Prog Med Chem, V22, P165, DOI 10.1016/S0079-6468(08)70231-5

[8] PAULUS W., 1963, ARCH TOXIKOLOGIE, V20, P38

[9] PISCHEK G, 1970, MIKROCHIM ACTA, P530

[10] SAID AS, 1981, THEORY MATH CHROMATO, P162